U.S. Department of Health & Human Services (HHS) mandates use of IICC’s Laboratory In Vitro Diagnostics (LIVD) standard for COVID-19 laboratory testing data reporting
On June 4, 2020 the U.S. Department of Health & Human Services (HHS) issued a guideline requiring that all COVID-19 (SARS-CoV-2) related laboratory testing data be reported using the appropriate LOINC and SNOMED codes, as defined by the IICC’s Laboratory In Vitro Diagnostics (LIVD) test code mapping.
LIVD (digital format for publication of LOINC to vendor IVD test results) defines the digital publication of LOINC using vendor defined IVD tests associated with a set of predefined LOINC codes. LIVD assures that laboratory personnel select the appropriate LOINC codes for IVD test used by their laboratory. It also allows LIS systems to automatically map the correct IVD vendor test result to a LOINC code.
For more information on LIVD go to https://ivdconnectivity.org
LIVD was developed by the IVD Industry Connectivity Consortium (IICC), a global, nonprofit organization dedicated to creating and encouraging adoption of a unified connectivity standard to reduce the cost and variability of data exchange between IVD devices and healthcare informatics. Member organizations include Abbott Diagnostics, Beckman Coulter, Becton Dickinson, bioMérieux, Data Innovations, Orchard Software, Ortho Clinical Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics, and Systelab Technologies, S.A.